Else Marie Agger - Concepedia

Author

Else Marie Agger

Also Known As

E Agger, E M Agger, E. M. Agger, E.M. Agger, Else Agger, Else M. Agger, Else Marie Agger, Else Marie Agger, Else M. Agger

113

Publications

Citations

H-Index

Concepts

All Affiliations

Statens Serum Institut University of Copenhagen Aston University University College Dublin University of Strathclyde

About

Else Marie Agger is an author at Statens Serum Institut specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	45	4.1K
2	Allergy	9	9	1.4K
3	Engineering	6	6	259
4	Biochemistry	6	6	602
5	Natural Sciences	3	3	475

Else Marie Agger

Publications

8.2K

Citations

H-Index

Page 1

	Year	Citations
The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons Elizabeth C. Carroll, Lei Jin, Andrés Mori, Immunity VaccinationMucosal VaccinationVaccine DevelopmentAllergyImmunology	2016	560
Cutting Edge: Mincle Is Essential for Recognition and Adjuvanticity of the Mycobacterial Cord Factor and its Synthetic Analog Trehalose-Dibehenate Hanne Schoenen, Barbara Bodendorfer, Kelly Hitchens, The Journal of Immunology	2010	483
Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells Thomas Lindenstrøm, Else Marie Agger, Karen Smith Korsholm, The Journal of Immunology VaccinationAllergyMedicineT-regulatory CellMycobacterium Tuberculosis	2009	422
Control of latentMycobacterium tuberculosis infection is dependent on CD8 T cells Laurens A.H. van Pinxteren, Joseph P. Cassidy, Birgitte H. C. Smedegaard, European Journal of Immunology	2000	357
Diagnosis of Tuberculosis Based on the Two Specific Antigens ESAT-6 and CFP10 Laurens A.H. van Pinxteren, Pernille Ravn, Else Marie Agger, Clinical and Diagnostic Laboratory Immunology	2000	340
Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate)—A novel adjuvant inducing both strong CMI and antibody responses Jesper Rømhild Davidsen, Ida Rosenkrands, Dennis Christensen, Biochimica et Biophysica Acta (BBA) - Biomembranes Microbial PathogensBiochemistryM. TuberculosisCationic LiposomesNatural Sciences	2005	340
Adjuvanticity of a synthetic cord factor analogue for subunit <i>Mycobacterium tuberculosis</i> vaccination requires FcRγ–Syk–Card9–dependent innate immune activation Kerstin Werninghaus, Anna Babiak, Olaf Groß, The Journal of Experimental Medicine	2009	311
Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements Else Marie Agger, Ida Rosenkrands, Jon Hansen, PLoS ONE	2008	287
Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6 Jan A. M. Langermans, T. Mark Doherty, Richard A. W. Vervenne, Vaccine VaccinologyVaccinationPulmonary TuberculosisMycobacterium Tuberculosis InfectionVaccine Development	2004	246
A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human Jaap T. van Dissel, Simone A. Joosten, Søren T. Hoff, Vaccine T-regulatory CellInnate Immune SystemImmune RegulationImmunologyImmunologic Mechanism	2014	237

Page 1